Oxypurinol

DRUG3 trials

Sponsors

Advanz Pharma, National Institutes of Health Clinical Center (CC), National Heart, Lung, and Blood Institute (NHLBI)

Conditions

Congestive Heart FailureHealthySickle Cell Disease

Phase 1

Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease

CompletedNCT00072826

National Institutes of Health Clinical Center (CC)Sickle Cell Disease

Start: 2003-11-04End: 2007-08-24Updated: 2019-12-12

Nitrite Infusion Studies

CompletedNCT00102271

National Heart, Lung, and Blood Institute (NHLBI)Healthy

Start: 2005-01-19End: 2011-04-12Updated: 2017-07-02

Phase 2

Oxypurinol Compared With Placebo for Class III-IV NYHA Congestive Heart Failure

CompletedNCT00063687

Advanz PharmaCongestive Heart Failure

Start: 2003-03-31End: 2005-06-30Target: 400Updated: 2005-08-05

Related Papers

Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study.

2008-06-01277 citations